News & Views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
November 09, 2021COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
November 09, 2021COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021
November 03, 2021COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder
October 22, 2021Our wellbeing programme at COMPASS
Anne Benedict, our Chief People Officer, talks about our approach to creating a workplace that supports mental health.